person · Reporting owner
Henderson Jeffrey William
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | January 27, 2026 | January 29, 2026 |
| HALOZYME THERAPEUTICS, INC.HALO · Entity 793 | Director | May 05, 2026 | May 07, 2026 |
| KYNTRA BIO, INC.FGEN · Entity 7431 | Director | September 01, 2023 | September 07, 2023 |
| QUALCOMM INC/DEQCOM · Entity 2852 | Director | March 17, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,143 |
Reported balance
After 2026-01-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 9,143 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectBy wife | 15 |
Reported balance
Holding disclosure · report date 2026-01-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2: Includes units acquired through dividend investment since the last report filed by the reporting person.
HALOZYME THERAPEUTICS, INC.
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,572 |
Reported balance
After 2026-05-05 transaction · row 1
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 3,796 · Balance 36,572 F1: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $65.87 · Expires 2036-05-05 | Direct | 6,040 |
Reported balance
After 2026-05-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-05 · Grant · Acquired 6,040 · Balance 6,040 F2: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.
F2: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.
KYNTRA BIO, INC.
Report date September 01, 2023 · Filed September 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,866 |
Reported balance
After 2023-09-01 transaction · row 1
1 source rowRow 1 · 2023-09-01 · Sale · Disposed 2,000 · Balance 28,866 F1: Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023. F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.970 to $1.075. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.
F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.970 to $1.075. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
QUALCOMM INC/DE
Report date March 17, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,598.6901 |
Reported balance
After 2026-03-17 transaction · row 1
1 source rowRow 1 · 2026-03-17 · Grant · Acquired 2,563 · Balance 14,598.6901 F1: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2026 Director Compensation Plan. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) March 17, 2029 (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2026 Director Compensation Plan. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) March 17, 2029 (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2022 Filed Mar 15, 2022 20:08 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Disposition to issuerCommon Stock | 1,469 | $152.34 | $223,787.46 |
DisclosureSEC source: 0001888316-22-000022 · edgardoc.xml · nonDerivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,105 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:08 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 4,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001888316-22-000022 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:10 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 1,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001888316-22-000017 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,485.6415 Underlying: Common Stock · 1,774 shares Expires not disclosed F1 · security: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2022 Director Compensation Plan. F2 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F3 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 18:44 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001583 · form4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,777 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036677 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036677 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 00:02 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | GrantRestricted Stock Units | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004972 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,839 F1 · shares: Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2022 and (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:29 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionDeferred Stock Unit · Derivative | 4,134.6854 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000026 · edgardoc.xml · derivative · entry 3 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,578.6065 Underlying: Common Stock · 4,134.6854 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:29 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Disposition to issuerCommon Stock | 1,333 | $140.33 | $187,059.89 |
DisclosureSEC source: 0001205233-21-000026 · edgardoc.xml · nonDerivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,015 Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:29 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000026 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 23:19 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000008 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,653.3815 Underlying: Common Stock · 1,922 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000008 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,918 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 23:59 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | SaleCommon Stock | 24,498 | $40.08 | $981,757.35 |
DisclosureSEC source: 0001179110-20-011428 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,609 F1 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.07 to $40.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:03 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | SaleCommon Stock | 6,000 | $141.10 | $846,602.40 |
DisclosureSEC source: 0001205233-20-000071 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,214 F1 · price: The sale prices for this transaction ranged from $140.80 to $141.48. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035148 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035148 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| April 30, 2020 Filed May 1, 2020 23:12 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | GrantCommon Stock | 8,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005378 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,107 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:19 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 3,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-20-000017 · edgardoc.xml · derivative · entry 4 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,454.0584 Underlying: Common Stock · 3,107 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:19 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionDeferred Stock Unit · Derivative | 4,644.6165 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-20-000017 · edgardoc.xml · derivative · entry 3 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,347.0584 Underlying: Common Stock · 4,644.6165 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:19 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Disposition to issuerCommon Stock | 1,497 | $78.89 | $118,098.33 |
DisclosureSEC source: 0001205233-20-000017 · edgardoc.xml · nonDerivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,214 Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:19 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 4,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-20-000017 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 13:33 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000013 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,089 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 22:54 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001209191-19-035651 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2029-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 22:54 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035651 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:15 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | GrantCommon Stock | 12,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005504 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,278 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2020 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 22:59 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 4,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-19-000024 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,567.6725 Underlying: Common Stock · 4,241 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:26 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionDeferred Stock Unit · Derivative | 5,099.4055 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-19-000015 · edgardoc.xml · derivative · entry 3 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,326.6725 Underlying: Common Stock · 5,099.4055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:26 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Disposition to issuerCommon Stock | 1,644 | $53.53 | $88,003.32 |
DisclosureSEC source: 0001205233-19-000015 · edgardoc.xml · nonDerivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,067 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:26 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 5,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-19-000015 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 14:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000006 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $55.30 | $0.00 |
DisclosureSEC source: 0001209191-18-036510 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036510 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| May 02, 2018 Filed May 2, 2018 23:40 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | GrantCommon Stock | 10,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006088 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,105 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 20:49 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 3,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-18-000020 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,972.716 Underlying: Common Stock · 3,758 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 21:06 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionDeferred Stock Unit · Derivative | 795.3308 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-18-000007 · edgardoc.xml · derivative · entry 3 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,214.716 Underlying: Common Stock · 795.3308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 21:06 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Disposition to issuerCommon Stock | 257 | $55.58 | $14,284.06 |
DisclosureSEC source: 0001205233-18-000007 · edgardoc.xml · nonDerivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612 Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 21:06 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 795 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-18-000007 · edgardoc.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 22:38 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $28.65 | $0.00 |
DisclosureSEC source: 0001209191-17-038998 · doc4.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable quarterly over one year measured from June 7, 2017. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:55 UTC | HALOZYME THERAPEUTICS, INC. HALO · Entity 793 | GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006695 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,742 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 21:21 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 4,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001234452-17-000039 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,569.9096 Underlying: Common Stock · 4,154 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| March 08, 2016 Filed Mar 10, 2016 18:28 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 4,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001234452-16-000381 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,270 Underlying: Common Stock · 4,539 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| January 12, 2016 Filed Jan 14, 2016 21:55 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 731 | $0.00 | $0.00 |
DisclosureSEC source: 0001234452-16-000335 · edgardoc.xml · derivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731 Underlying: Common Stock · 731 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.